by management-led consortium including Robert A. Ortenzio and WCAS
- RBC Capital downgraded Select Medical to Sector Perform from Outperform and cut its price target to $16.50
- RBC cited the company’s agreement to be acquired for $16.50 per share by a management-led consortium as rationale
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.